Vala Sciences
Vala Sciences is a privately held company founded in 2004 that provides advanced in vitro drug candidate screening services using a proprietary platform that measures single-cell kinetics of human induced pluripotent stem cells (hiPSC). Their flagship product, the Kinetic Image Cytometer (KIC®), captures and analyzes electrical and contractile events in cells at high throughput, enabling precise prediction of drug safety and efficacy. The company leverages its CyteSeer® cell analysis software and the ValaDATE™ AI platform to rank-order drug candidates by toxicity and efficacy, reducing costly clinical failures and animal studies. Vala has established Centers of Excellence at leading research institutions and has received over $20 million in NIH grants, positioning it as a leader in preclinical drug screening with a strong scientific and academic collaboration track record.
Vala Sciences
Vala Sciences is a privately held company founded in 2004 that provides advanced in vitro drug candidate screening services using a proprietary platform that measures single-cell kinetics of human induced pluripotent stem cells (hiPSC). Their flagship product, the Kinetic Image Cytometer (KIC®), captures and analyzes electrical and contractile events in cells at high throughput, enabling precise prediction of drug safety and efficacy. The company leverages its CyteSeer® cell analysis software and the ValaDATE™ AI platform to rank-order drug candidates by toxicity and efficacy, reducing costly clinical failures and animal studies. Vala has established Centers of Excellence at leading research institutions and has received over $20 million in NIH grants, positioning it as a leader in preclinical drug screening with a strong scientific and academic collaboration track record.